Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.

Drugs R D · 2018 · PMC6131117 · PMID 30171515

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

As a secondary outcome analysis, there was a clear trend toward improved neurocognitive functioning in the patients receiving aripiprazole.

also in 19,460 other papers

showed a trendno p-value reported

Two trials with olanzapine did not show significant improvement compared with placebo, and five trials with quetiapine only showed a trend toward improvement with antipsychotic treatment, with no statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.